Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Figure 9

K-M survival curves for stem cell-related markers based on TCGA-OV patient survival data. (a) Unfavorable prognosis of patients at low CBX2 expression, and this association was not statistically significant. (b) Poor survival prognosis was observed in patients with high C19orf33 expression, and this association was not statistically significant. (c) Patients with elevated SLC38A4 expression levels had poor survival prognosis, and this association was statistically significant. (d) Poor survival prognosis of patients with high INSRR expression and, this association was statistically significant. (e) Patients with high CSMD1 expression had poor survival prognosis, and this association was not statistically significant. (f) Worse survival prognosis of patients with low PRLR expression, and this association was not statistically significant.

(a)

(b)

(c)

(d)

(e)

(f)